HomeLPCN • NASDAQ
Lipocine Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 93.86K | -98.77% |
Operating expense | 2.18M | -50.30% |
Net income | -1.86M | -153.08% |
Net profit margin | -1.99K | -4,406.92% |
Earnings per share | — | — |
EBITDA | -2.08M | -164.37% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.72M | -19.95% |
Total assets | 20.50M | -19.44% |
Total liabilities | 1.30M | -12.78% |
Total equity | 19.20M | — |
Shares outstanding | 5.35M | — |
Price to book | 1.04 | — |
Return on assets | -24.30% | — |
Return on capital | -25.72% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.86M | -153.08% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$3.73
Day range
$3.60 - $4.23
Year range
$2.68 - $11.79
Market cap
19.26M USD
Avg Volume
21.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1997
Headquarters
Website
Employees
16
